Pneumonia News and Research

Latest Pneumonia News and Research

NBA Cares, SAHM and Tulsa Shock guard partner for teen vaccine awareness campaign

Tulsa Shock guard Andrea Riley and Basketball Hall of Famer Bob Lanier teamed up with NBA Cares and the Society for Adolescent Health and Medicine today to bring Vaccines for Teens to the Tulsa community.

5 May 2011

Addition of family physicians linked to reduced risk of hospital readmissions

Researchers from Boston University School of Medicine and Boston Medical Center have found that by adding one family physician per 1,000, or 100 per 100,000, could reduce hospital readmission costs by $579 million per year, or 83 percent of the Patient Protection and Affordable Care Act target.

4 May 2011

New research shows honey fights drug-resistant germs

Herbal ingredients and natural nutrients are often capable of supporting different functions within the body, and current research is showing that a certain kind of honey may be useful in fighting drug-resistant germs.

2 May 2011

Penn State launches unique oral hygiene approach for dementia patients

Nurses who care for patients with dementia now have a tailored approach to dental hygiene for their charges, thanks to a pilot study by a team of nurses.

2 May 2011

Penn Nursing, Surgeon General partner to promote breastfeeding awareness in the U.S.

While 75 percent of U.S. babies start out breastfeeding, the U.S. Centers for Disease Control and Prevention reports only 13 percent are exclusively breastfed at the end of six months. Six months of exclusive breastfeeding is the American Academy of Pediatrics' minimum recommendation.

30 Apr 2011

AACN to present Flame of Excellence Award to VCU researcher

The American Association of Critical-Care Nurses will present the Flame of Excellence Award to noted researcher and educator Mary Jo Grap, RN, PhD, FAAN, professor, School of Nursing, Virginia Commonwealth University, Richmond.

30 Apr 2011

Spectrum receives FDA approval for FUSILEV to treat colorectal cancer

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, received approval from the U.S. Food and Drug Administration on April 29, 2011, for the use of FUSILEV in combination with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer.

30 Apr 2011

Nursing environment linked to improved patient outcomes

Better working conditions and better staffing of nurses can significantly improve the care of patients with serious conditions, according to the latest nurse labor study by the University of Maryland School of Nursing.

28 Apr 2011

The Lancet publishes phase 3 clinical study data on VIVITROL for treatment of opioid dependence

Alkermes, Inc. today announced that results from the phase 3 clinical study of VIVITROL® (naltrexone for extended-release injectable suspension) in opioid dependence have been published by The Lancet. The six-month, phase 3 trial met its primary endpoint and showed significantly greater opioid-free weeks among patients treated with VIVITROL, compared to placebo.

28 Apr 2011

Azithromycin holds promise for preventing BPD in Ureaplasma-infected preterm infants

A study performed by University of Kentucky researchers shows promise for the use of azithromycin in treating Ureaplasma-colonized or infected premature infants to prevent bronchopulmonary dysplasia (BPD).

27 Apr 2011

Millennium submits two VELCADE sNDAs to FDA

Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that it has submitted two supplemental new drug applications (sNDAs) for VELCADE® (bortezomib) for Injection to the U.S. Food and Drug Administration. The first application seeks to add a subcutaneous route of administration for VELCADE. The second application is for the use of VELCADE in combination with rituximab in patients with relapsed follicular non-Hodgkin lymphoma (NHL).

26 Apr 2011

PolyMedix defensin-mimetic antibiotic compounds show antimicrobial efficacy against anthrax

PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat patients with acute infectious diseases and cardiovascular disorders, announced today that several of its defensin-mimetic antibiotic compounds have shown antimicrobial efficacy in an animal model against the bacteria that causes anthrax.

26 Apr 2011

Infants with bronchopulmonary dysplasia can benefit from azithromycin therapy

A study performed by University of Kentucky researchers shows promise for the use of azithromycin in treating Ureaplasma-colonized or infected premature infants to prevent bronchopulmonary dysplasia.

26 Apr 2011

FDA approves Spectrum's FUSILEV Injection to treat metastatic colorectal cancer

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that the U.S. Food and Drug Administration has approved the Company's Supplemental New Drug Application for FUSILEV Injection.

22 Apr 2011

WSU researcher develops potential vaccine for Chlamydia

A Wayne State University School of Medicine researcher has developed a potential first ever vaccine for Chlamydia, the world's most prevalent sexually transmitted disease and the leading cause of new cases of blindness.

21 Apr 2011

Meridian Bioscience second quarter net sales increases 32% to $41.1 million

Meridian Bioscience, Inc., today reported fiscal 2011 second quarter and six months net sales of $41.1 million and $78.3 million, respectively, increases of 32% and 6%, respectively, from the same periods of the prior fiscal year;

21 Apr 2011

Shanghai Pharmaceutical and Pfizer enter MOU to pursue potential business opportunities

Shanghai Pharmaceutical Co. Ltd. and Pfizer Inc. today announced the signing of a memorandum of understanding (MOU) for the companies to jointly pursue potential business opportunities in China.

21 Apr 2011

CMS unveils 2012 hospital Medicare payment proposal

The American Hospital Association responded by saying it was "deeply disappointed" by the proposal, which would cut acute-care hospital payments in the coming year.

21 Apr 2011

Gilead, MicroDose enter collaboration for inhalable small molecule antiviral fusion inhibitor MDT-637

Gilead Sciences, Inc. and MicroDose Therapeutx, Inc. today announced that the companies have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of MDT-637, MicroDose's inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus (RSV).

20 Apr 2011

Furiex acquires full rights to JNJ-Q2, a novel broad-spectrum fluoroquinolone antibiotic

Furiex Pharmaceuticals, Inc. announced today that it has acquired full exclusive license rights to develop and commercialize the compound JNJ-Q2 under its existing development and license agreement with Janssen Pharmaceutica N.V.. Furiex acquired these rights as a result of Janssen's decision not to exercise its option under the agreement that gave Janssen the opportunity to continue development of JNJ-Q2.

20 Apr 2011

Pneumonia News and Research

Latest Pneumonia News and Research

NBA Cares, SAHM and Tulsa Shock guard partner for teen vaccine awareness campaign

Addition of family physicians linked to reduced risk of hospital readmissions

New research shows honey fights drug-resistant germs

Penn State launches unique oral hygiene approach for dementia patients

Penn Nursing, Surgeon General partner to promote breastfeeding awareness in the U.S.

AACN to present Flame of Excellence Award to VCU researcher

Spectrum receives FDA approval for FUSILEV to treat colorectal cancer

Nursing environment linked to improved patient outcomes

The Lancet publishes phase 3 clinical study data on VIVITROL for treatment of opioid dependence

Azithromycin holds promise for preventing BPD in Ureaplasma-infected preterm infants

Millennium submits two VELCADE sNDAs to FDA

PolyMedix defensin-mimetic antibiotic compounds show antimicrobial efficacy against anthrax

Infants with bronchopulmonary dysplasia can benefit from azithromycin therapy

FDA approves Spectrum's FUSILEV Injection to treat metastatic colorectal cancer

WSU researcher develops potential vaccine for Chlamydia

Meridian Bioscience second quarter net sales increases 32% to $41.1 million

Shanghai Pharmaceutical and Pfizer enter MOU to pursue potential business opportunities

CMS unveils 2012 hospital Medicare payment proposal

Gilead, MicroDose enter collaboration for inhalable small molecule antiviral fusion inhibitor MDT-637

Furiex acquires full rights to JNJ-Q2, a novel broad-spectrum fluoroquinolone antibiotic

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Pneumonia News and Research

Latest Pneumonia News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in